Ping An Biomedical Co., Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PASW | 8471.HK | WHE.F | 0146.HK | CLIK | 3398.HK | |
|---|---|---|---|---|---|---|
| Market cap | 8.27M | 16.40M | 105.91M | 338.44M | 6.47M | 239.38M |
| P/E (TTM) | — | — | 7.7 | 7.3 | 3.2 | — |
| Forward P/E | — | — | — | — | — | — |
| Price/book | 0.8 | 0.3 | 0.3 | 0.7 | 0.2 | 0.2 |
| Dividend yield | — | — | 9.95% | 7.52% | — | — |
| 1-year change | −80.00% | −93.27% | −46.90% | −11.39% | −89.78% | +27.71% |
| Today | −40.93% | −3.04% | −0.65% | −3.33% | +2.48% | +7.55% |
The closest companies by business and industry (Textile Manufacturing). Prices may be delayed up to 15 min.
Latest news
All PASW news ›Ping An Biomedical Enters Into Patent Purchase Agreement For Tumor Cell Technologies
TradingView Ping An Biomedical Enters Into Patent Purchase Agreement For Tumor Cell Technologies
Adicet Bio announces reverse stock split
Adicet Bio Inc: Adicet Bio announces reverse stock split Adicet Bio Inc - announces one-for-16 reverse stock split ... Biotechnology & Medical Research Adicet Bio announces reverse stock split Published on 12/26/2025 at 09:18 am EST
Ping An Biomedical Announces 1-for-40 Reverse Stock Split
Class A Ordinary Shares Expected to Begin Trading on a Split-Adjusted Basis on October 23, 2026 HONG KONG, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) ("Ping An Bio” or the "Company”) announced that its…
Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years
HONG KONG, July 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (hereinafter referred to as “Ping An Biomedical”) annou... Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting…
Ping An Biomedical Co Ltd trading halted, news pending
19:50 EDT Ping An Biomedical Co Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving b... Ping An Biomedical Co Ltd trading halted, news pending 19:50 EDT Ping An Biomedical Co Ltd…
Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio
HONG KONG, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the âCompanyâ) today HONG KONG, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the âCompanyâ) today announced…
Ping An Biomedical Enters LOI to Acquire Oncology and Biotechnology Patents for Planned Healthcare IP Portfolio Expansion
Ping An Biomedical plans to acquire three oncology patents from Future Biotechnology for $2 million to $2.5 million, enhancing its R&D strategy. Ping An Biomedical intends to acquire three tumor cell-related medical technology patents for…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com4
- manilatimes.net2
- markets.financialcontent.com1
- marketscreener.com1
- quiverquant.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.